As followers of the anticorruption blogosphere know, China recently fined British pharmaceutical giant GlaxoSmithKline (“GSK”) $490 million for bribing Chinese doctors and hospital administrators. There is no need rehash here what many others have already said: this case is likely a watershed … Continue reading Prosecuting GSK: How to Deal with Being Second in Line
Copy and paste this URL into your WordPress site to embed
Prosecuting GSK: How to Deal with Being Second in Line
As followers of the anticorruption blogosphere know, China recently fined British pharmaceutical giant GlaxoSmithKline (“GSK”) $490 million for bribing Chinese doctors and hospital administrators. There is no need rehash here what many others have already said: this case is likely a watershed … Continue reading Prosecuting GSK: How to Deal with Being Second in Line